Alcobra Ltd.
Quick facts
Marketed products
- Metadoxine extended release · Hepatology / Addiction Medicine
Metadoxine is a combination of pyridoxine (vitamin B6) and L-2-aminoethanol that enhances acetaldehyde metabolism and reduces its toxic accumulation in alcohol-related disorders.
Phase 2 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Alcobra Ltd.
What are Alcobra Ltd.'s marketed drugs?
Top marketed products include Metadoxine extended release.
Related
- Metadoxine extended release · Hepatology / Addiction Medicine
- Sector hub: All tracked pharma companies